onychomycosis: 1064-nm nd:yag q-switch laser treatment
TRANSCRIPT
Journal of Cosmetic Dermatology, 13, 232--235
Onychomycosis: 1064-nm Nd:YAG q-switch laser treatment
Hector Ricardo Galvan Garcia, MD
Dermatology Hospital, Dermatosurgery, Guadalajara, Jalisco, Mexico
Summary Background Laser Treatment of onychomycosis is a quick and easy method without
complications.
Aim Laser therapy is efficient for the Treatment of onychomycosis.
Material & Methods One hundred and twenty patients with a KOH (+) confirmed
clinical diagnosis of onychomycosis were included in this study, all of the patients
were treated in a single sesi�on with a 1064-nm neodymium-doped yttrium-
aluminum garnet (Nd:YAG) q-switch laser.
Results There was a 100% clinical response rate within the 9 month follow-up period
with no side effects.
Conclusi�on This method is proposed as a novel and safe method for the treatment of
this ungual pathology.
Keywords: onychomycosis, Nd:YAG laser
Introduction
At present, laser treatment for onychomycosis is con-
sidered common practice because it is simple, quick
and presents no complications.3 Recently, alternatives
to the 1064-nm Nd:YAG laser treatment have been
proposed: q-switch laser, long-pulse laser,4 and the
combination of both of these methods (Alma Laser
Modules).1 Although all of these methods yield similar
results, there is a great difference in the number of ses-
sions, settings and the necessary time that the doctor
and the patient need to complete the treatment. The
objective of our study was to demonstrate the effective-
ness, speed, and the minimum number of sessions
needed to achieve the best results during laser treat-
ment of onychomycosis.
Material and methods
One hundred and twenty patients were included in the
study from April 2012 to December 2013. All of the
patients had a KOH (+)-confirmed diagnosis of clinical
onychodystrophy resulting from hand or foot ungual
onychomycosis of the distal, proximal, or lateral type.
Patients of all ages who had not previously received
any type of treatment were included. Each patient
signed a consent form and permitted clinical photo-
graphs of their nails to be taken before and after the
laser therapy.
Pregnant patients and patients with a subungual
hematoma were excluded. In addition, patients taking
photosensitive medication and patients with psoriasis,
lichen, or atopic dermatitis with nail involvement were
also excluded.
A direct microscopic test was performed with a mix
of KOH (25%) and glycerol (5%) (1 h at 51–54 °C) forlipid emulsification, and mycological structures were
identified under 4009 magnification. This test was per-
formed at the beginning and at the end of the study
for each patient.
Correspondence: Dermatology Hospital, Dermatosurgery, Lopez Cotilla
2261 Colonia Arcos Vallarta, C.P.44130. Guadalajara, Jalisco, Mexico.
E-mail: [email protected]
Accepted for publication May 21, 2014
232 © 2014 Wiley Periodicals, Inc.
Journal Innovention
Laser therapy
Laser therapy was performed randomly with two
1064-nm Nd:YAG q-switch laser equipment. The first
laser was a Monalisa Laser, Sincoheren Co., Xizhimen
Beidajie, Beijing, China; the second laser was a Q-Clear
TM, Light Age, Inc., Somerset, NJ, USA. The lasers’ set-
tings were adjusted to yield a fluency of 600 mJ/cm2
over a 3-mm spot at a 3-Hz frequency in a single ses-
sion. Three applications were performed in a squared
form across the entire ungual plate for each case
(about 300 shots for nail). Immediate changes after
laser light application were observed (nail clearance).
Treatment questionnaires and clinical revisions were
scheduled at 3, 6 and 9 months after treatment.
Results
One hundred and twenty patients were included in the
clinical study, 98 women and 22 men. Patients were
between 6 and 79 years of age, including 118 adults
and 2 children (6- and 10-year old, both female). A
total of 733 nails were treated, 714 toenails and 19
fingernails. Four patients had both affected toenails
and affected fingernails affected. There was a 93% clin-
ical response rate within 3 months of the initial laser
treatment. There was a 100% clinical response rate at
6 months. At 9 months, there was a 100% clinical
and mycological response (KOH�) rate (Figs 1–4).There were no recorded side effects.
Discussion
The greatest advantages of laser treatment for onycho-
mycosis compared with traditional treatments such as
oral or topical medications are the ease of application,
negligible contraindications, and overall absence of side
effects.
In our study, we decided to test our patients only
with KOH and not to perform cultures because various
prior publications have shown that the KOH test shows
a higher specificity (60–80% vs. 30–60% for cul-
tures).5–8,10 Moreover, there was a high incidence ofFigure 1 Pretherapy laser.
Figure 2 Posttherapy laser six months after.
Figure 3 Pretherapy laser.
© 2014 Wiley Periodicals, Inc. 233
Onychomycosis, Nd:YAG laser . H R Galvan Garcia
Trichophyton rubrum in these studies as the main caus-
ative agent of onychomycosis.
In previous studies 2 and,9 the inhibition of T. rubrum
has been described in colonies exposed to 1064-nm Nd:
YAG q-switch laser radiation at 4 and 8 J/cm2. More-
over, Meral and Tasar 6 have reported a significant
in vitro reduction of Candida albicans growth using this
laser therapy.
During the laser therapy, we observed near-instanta-
neous clearance of the affected nails, particularly nails
that showed a brown-black or dark green pigmentation
(Figs 5 and 6). In addition, we observed the clearance
of the characteristic “cracking” sound in the fungus-
affected areas of the ungual plate and in the clinically
free zones where there was no sound after the treat-
ment. The Nd:YAG q-switch laser has been described
under this name because it generates high-energy
peaks with many repetitions. It does not warm the tis-
sue (it is painless); thus, it produces impact energy that
mechanically damages only the objective of interest
(fungi).
Based on the above-mentioned clinical findings, we
suggest that laser therapy acts via “selective photo-
thermolysis” that works according to the type of pig-
ment, type of light used, and pulse frequency
(light + heat + impact power).
Conclusions
The present study confirmed the efficacy of laser ther-
apy for the treatment of onychomycosis in all of its
clinical manifestations, including in the hands and feet
and in all age groups, without side effects. This therapy
was quick and effective, and only a single session with
a 1064-nm Nd:YAG q-switch laser was required. No
differences were found in the therapeutic responses
between the different lasers utilized.
References
1 Alma Laser Modules Operator’s Manual 2012; Ch. 25.
2 Gupta AK, Ahmad I, Burst I et al. Detection of xantho-
megnin in epidermal materials infected with Trichophyton
rubrum. J Invest Dermatol 2000; 115: 901–5.
Figure 4 Posttherapy laser one year after.
Figure 5 Pretherapy laser.
Figure 6 Posttherapy laser, near-instantaneous clearance.
234 © 2014 Wiley Periodicals, Inc.
Onychomycosis, Nd:YAG laser . H R Galvan Garcia
3 Kozarev J, Vizintin Z. Novel laser therapy in treatment of
onychomycosis. J Laser Health Acad 2010; 1: 1–9.4 Kozarev J. ClearSteps – Laser Onychomycosis Treatment:
Assessment of Efficacy 12 months After Treatment and
Beyond. 2012. Available at: http://www.laserandhealth-
academy.com/media/objave/academy/priponke/4.koza-
rev_clearsteps.pdf.
5 Meireles TEF, Rocha MFG, Brilhante RSN et al. Successive
mycological nail testing for onychomycosis: a strategy for
efficient diagnosis. Braz J Infect Dis 2008; 12: 333–7.6 Meral G, Tasar F, Kocagoz S. Factors affecting the anti-
bacterial effects of Nd:YAG laser in vivo. Lasers Surg Med
2003; 32: 197–202.7 Nazar JR, Gerosa PE, Diaz OA. Onicomicosis: Epidemiolo-
gia, Agentes Causales y Evaluacion de los Metodos Diag-
nosticos de Laboratorio [Onychomycoses: epidemiology,
causative agents and assessment of diagnostic laboratory
methods.]. Rev Argent Microbiol 2012; 44: 21–5.8 Shemer A, Trau H, Davidovici B et al. Nail sampling in
onychomycosis: comparative study of curettage from
three sites of the infected nail. J Dtsch Dermatol Ges 2007;
5: 1108–11.9 Smijs TG, Schuitmaker HJ. Photodynamic inactivation of
the dermatophyte Trichophyton rubrum. Photochem Photo-
biol 2003; 77: 556–60.10 Weinberg JM, Koestenblatt EK, Tutrone WD et al. Com-
parison of diagnostic methods in the evaluation of ony-
chomycosis. J Am Acad Dermatol 2003; 49: 193–7.
© 2014 Wiley Periodicals, Inc. 235
Onychomycosis, Nd:YAG laser . H R Galvan Garcia